Saint Luke's Heart Failure Program

National leader in treating heart failure

Our team of subspecialty trained experts are dedicated to helping patients live full lives through comprehensive heart failure treatment.

Saint Luke’s Mid America Heart Institute offers a full range of heart failure treatment options. Using a combination of medicine, surgery, and symptom management strategies, each patient receives a personalized care plan.

Our program includes:

  • Expert management of all types and stages of heart failure
  • Ten heart failure cardiologists certified in advanced heart failure and transplant cardiology through the American Board of Internal Medicine
  • Dedicated specialty clinics to care for patients with heart failure from amyloidosis and hypertrophic cardiomyopathy
  • Full spectrum of surgical support for advanced heart failure, including extracorporeal membrane oxygenation (ECMO)mechanical assist devices (VAD), and heart transplantation
  • Cardiologists board certified in adult congenital heart disease who specialize in treating patients at risk of developing heart failure as adults
  • Cardiopulmonary exercise testing to determine patients' physical capacity
  • Clinical research trials to evaluate new medications and procedures for heart failure
  • Ability to implant pressure monitors (CardioMEMS™ HF System) in the heart to help detect pressure build-up before symptoms worsen

Nationally Recognized Care

Advanced Certification in Heart Failure by The Joint Commission: Saint Luke’s Hospital has been certified since 2014. Our program provides the next generation of heart failure care to patients in the hospital and outpatient settings and fosters exceptional outcomes for heart failure patients.

Get With The Guidelines Heart Failure® Gold Plus Target: Heart Failure Honor Roll Quality Achievement Award: Recognition from the American Heart Association for our excellence in implementing the latest treatment guidelines for heart failure patients.

Recognized as High Performing by U.S. News & World Report for heart failure.

Make an appointment: call 816-931-1883

 

Providers

Bethany A Austin, MD

Advanced Heart Failure/Transplant Cardiology, Cardiology

Mark P Everley, MD

Advanced Heart Failure/Transplant Cardiology, Cardiology

Andrew C Kao, MD

Cardiology, Advanced Heart Failure/Transplant Cardiology

Taiyeb M Khumri, MD

Advanced Heart Failure/Transplant Cardiology, Cardiology

Stephanie L Lawhorn, MD

Cardiology, Advanced Heart Failure/Transplant Cardiology

Anthony Magalski, MD

Advanced Heart Failure/Transplant Cardiology, Cardiology

Michael E Nassif, MD

Cardiology, Hospitalist

Andrew James Sauer, MD

Cardiology, Advanced Heart Failure/Transplant Cardiology

Brett W Sperry, MD

Advanced Heart Failure/Transplant Cardiology, Cardiology

Ahmad Ziad Turk, MD

Cardiology, Advanced Heart Failure/Transplant Cardiology

Deepthi Vodnala, MD

Advanced Heart Failure/Transplant Cardiology, Cardiology

Sarah A Brown, RN, ANP

Nurse Practitioner

Kasey Dawn Dunn, RN, APRN

Nurse Practitioner

Nearest Locations

Saint Luke's Cardiovascular Consultants

Saint Luke's Cardiovascular Consultants

Saint Luke's Cardiovascular Consultants

Saint Luke's Cardiovascular Consultants

Saint Luke's Hospital of Kansas City and Saint Luke's East Hospital

News

Saint Luke's Mid America Heart Institute
Oct. 28, 2021
PRESERVED-HF trial findings on the substantial impact of dapagliflozin in individuals with heart failure with preserved ejection fraction (HFpEF) published in Nature Medicine
The findings of the PRESERVED-HF trial, offering potential new hope for people struggling with heart failure with preserved ejection fraction (HFpEF), are published in the journal, Nature Medicine.
Aug. 19, 2021
Managed Healthcare Executive: Mavacamten, First-in-Class Therapy, May Soon Be Available for Hypertrophic Cardiomyopathy
A therapy on the horizon could be the first to specifically treat the underlying cause of hypertrophic cardiomyopathy.